Sex Differences in Vestibular Schwannoma.

facial palsy gender medicine microsurgical resection quality of life sex vestibular schwannoma

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
01 Sep 2023
Historique:
received: 08 08 2023
revised: 22 08 2023
accepted: 29 08 2023
medline: 9 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Vestibular schwannoma (VS) are equally common in men and woman. A number of epidemiological studies have reported on sex-specific aspects of incidence, tumor size, tinnitus and hearing loss. However, data on sex-specific, pre- and post-surgically quality of life (QoL) are rare. The objective of the present study was to determine sex-specific aspects on QoL in VS. Health-related QoL was analyzed in 260 patients (112 male/148 female) with unilateral sporadic VS using general (SF-36: general Short-Form Health Survey), disease-specific (PANQOL: Penn Acoustic Neuroma Quality-of-Life Scale, PANQOL) and symptom-specific (DHI: Dizziness Handicap Inventory; HHI: Hearing Handicap Inventory; THI: Tinnitus Handicap Inventory; FDI: Facial Disability Index) QoL questionnaires. Sex differences were evaluated pre- and postoperative by multi- and univariate analyses based on 200 preoperative and 88 postoperative questionnaires. Female patients were significantly more affected by dizziness, headaches, reduced energy and anxiety. Energy and balance changed similarly in both sexes after surgery. However, postoperative women tended to be more affected by facial palsy and headaches than men. Despite the greater physical impairment, general health improved equivalently or even more in female patients than in males. In conclusion, self-rated QoL in VS is significantly affected by sex and surgery. This should be taken into account when counseling VS patients regarding observation, radiotherapy, and surgery.

Identifiants

pubmed: 37686642
pii: cancers15174365
doi: 10.3390/cancers15174365
pmc: PMC10486905
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Am J Psychiatry. 1997 Dec;154(12):1641-7
pubmed: 9396940
Br J Oral Maxillofac Surg. 2022 Apr;60(3):326-331
pubmed: 34690015
Asian Nurs Res (Korean Soc Nurs Sci). 2020 Feb;14(1):50-55
pubmed: 31996321
Nature. 2010 Jun 10;465(7299):665
pubmed: 20535156
Front Neurol. 2017 Aug 03;8:378
pubmed: 28824535
Nervenarzt. 2019 Jun;90(6):578-586
pubmed: 31076802
JAMA Facial Plast Surg. 2017 May 01;19(3):190-196
pubmed: 27930763
Otol Neurotol. 2020 Dec;41(10):e1372-e1378
pubmed: 33492815
Arch Gen Psychiatry. 1994 Jan;51(1):8-19
pubmed: 8279933
Br J Health Psychol. 2020 Sep;25(3):695-727
pubmed: 32538540
Acta Neurochir (Wien). 2001;143(6):587-91
pubmed: 11534675
J Pers Med. 2022 Sep 30;12(10):
pubmed: 36294756
Otolaryngol Head Neck Surg. 2019 Nov;161(5):846-851
pubmed: 31310582
Adv Clin Exp Med. 2020 Jun;29(6):751-755
pubmed: 32589823
Acta Otolaryngol. 2020 May;140(5):373-377
pubmed: 32049565
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1278-82
pubmed: 12933936
Otolaryngol Head Neck Surg. 1985 Apr;93(2):146-7
pubmed: 3921901
Clin Chem Lab Med. 2013 Apr;51(4):713-27
pubmed: 23515103
Curr Opin Neurol. 2022 Feb 1;35(1):135-141
pubmed: 34864753
Natl J Maxillofac Surg. 2017 Jul-Dec;8(2):149-152
pubmed: 29386819
Otol Neurotol. 2018 Oct;39(9):1203-1209
pubmed: 30199503
Laryngoscope. 2000 Sep;110(9):1539-42
pubmed: 10983957
Physiol Behav. 1993 Dec;54(6):1119-24
pubmed: 8295951
J Negat Results Biomed. 2009 Nov 04;8:9
pubmed: 19889208
J Neurosurg. 2011 Feb;114(2):381-5
pubmed: 20486891
J Craniofac Surg. 2014 Sep;25(5):e418-20
pubmed: 25153061
Skull Base. 2008 Nov;18(6):377-84
pubmed: 19412407
Neuro Oncol. 2020 Jan 11;22(1):31-45
pubmed: 31504802
J Clin Epidemiol. 1998 Nov;51(11):1167-70
pubmed: 9817134
Otolaryngol Head Neck Surg. 2018 Oct;159(4):717-723
pubmed: 29712512
Otolaryngol Clin North Am. 2012 Apr;45(2):257-68, vii
pubmed: 22483814
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2017 Dec 18;16:Doc03
pubmed: 29279723
J Neurosurg. 2010 Jan;112(1):163-7
pubmed: 19538047
Support Care Cancer. 2013 May;21(5):1365-72
pubmed: 23238654
Front Oncol. 2023 Jun 26;13:1152833
pubmed: 37434979
Neurosurgery. 2019 Sep 1;85(3):409-414
pubmed: 30169695
Neurosurgery. 1997 Jan;40(1):1-9; discussion 9-10
pubmed: 8971818
Clin Neurol Neurosurg. 2011 Jan;113(1):52-6
pubmed: 20965648
Cancers (Basel). 2020 Nov 25;12(12):
pubmed: 33255551
Otol Neurotol. 2019 Jan;40(1):88-95
pubmed: 30289843
J Neurosurg. 2015 Apr;122(4):833-42
pubmed: 25555165
Otol Neurotol. 2011 Jan;32(1):158-62
pubmed: 21099731
J Plast Reconstr Aesthet Surg. 2023 Feb;77:408-415
pubmed: 36638757
J Neurosurg. 2011 Oct;115(4):820-6
pubmed: 21682562

Auteurs

Kathrin Machetanz (K)

Department of Neurosurgery and Neurotechnology, Eberhard Karls University, 72074 Tuebingen, Germany.

Sophie S Wang (SS)

Department of Neurosurgery and Neurotechnology, Eberhard Karls University, 72074 Tuebingen, Germany.

Linda Oberle (L)

Department of Neurosurgery and Neurotechnology, Eberhard Karls University, 72074 Tuebingen, Germany.

Marcos Tatagiba (M)

Department of Neurosurgery and Neurotechnology, Eberhard Karls University, 72074 Tuebingen, Germany.

Georgios Naros (G)

Department of Neurosurgery and Neurotechnology, Eberhard Karls University, 72074 Tuebingen, Germany.

Classifications MeSH